Results 51 to 60 of about 234 (105)

Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1. [PDF]

Genet Med, 2020
Ottenhoff MJ, Rietman AB, Mous SE, Plasschaert E, Gawehns D, Brems H, Oostenbrink R, ENCORE-NF1 Team, van Minkelen R, Nellist M, Schorry E, Legius E, Moll HA, Elgersma Y.   +13 more
europepmc   +1 more source

Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targets. [PDF]

Acta Neuropathol Commun
Brunet A, Coulpier F, Onfroy A, Sako N, Radomska KJ, Aftimos V, Lacroix L, Briand-Suleau A, Maille P, Hermeziu O, Laurendeau I, Pasmant E, Wolkenstein P, Topilko P, Ortonne N.   +14 more
europepmc   +1 more source

The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1. [PDF]

PLoS One, 2020
Well L, Jaeger A, Kehrer-Sawatzki H, Farschtschi S, Avanesov M, Sauer M, de Sousa MT, Bannas P, Derlin T, Adam G, Mautner VF, Salamon JM.   +11 more
europepmc   +1 more source

Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience. [PDF]

Parkinsonism Relat Disord, 2021
de Rus Jacquet A, Bogard S, Normandeau CP, Degroot C, Postuma RB, Dupré N, Miyasaki JM, Monchi O, Martino D, Fon EA, Cicchetti F.   +10 more
europepmc   +1 more source

Whole-body MRI-based long-term evaluation of pediatric NF1 patients without initial tumor burden with evidence of newly developed peripheral nerve sheath tumors. [PDF]

Orphanet J Rare Dis
Schmalhofer ML, Farschtschi S, Kluwe L, Mautner VF, Adam G, Well L, Ristow I.   +6 more
europepmc   +1 more source

Experiences of stigmatization and its impacts among individuals living with hereditary diseases and family members in Portugal: an exploratory study. [PDF]

J Community Genet
Valentim J, Paneque M, Mendes Á.
europepmc   +1 more source

[Plexiform cervical neurofibroma: about a case]. [PDF]

Pan Afr Med J, 2018
Bouimetarhan L, Bellamlih H, En-Nafaa I, Fenni JE, Amil T, Radouane B.   +5 more
europepmc   +1 more source

[Temps forts des Journées dermatologiques de Paris 2020]. [PDF]

Eur J Dermatol, 2021
Aubert H, Frenard C.
europepmc   +1 more source

Eruptive neurofibromas in pregnancy. [PDF]

Ann Afr Med, 2020
Yahya H, Sani H.
europepmc   +1 more source

Neurofibromatosis type 1 adult surveillance form for Austria. [PDF]

Wien Klin Wochenschr
Sunder-Plassmann V, Azizi AA, Farschtschi S, Gruber R, Hutterer M, Ladurner V, Röhl C, Welponer T, Bergmeister-Berghoff AS.   +8 more
europepmc   +1 more source